In vitro and in vivo analysis of the effects of corticotropin releasing factor on rat dorsal vagal complex

Mark W. Lewis, Gerlinda E. Hermann, Richard C. Rogers, R. Alberto Travagli

Research output: Contribution to journalReview article

63 Citations (Scopus)

Abstract

In vivo and in vitro electrophysiological experiments were performed on the rat dorsal vagal complex (DVC, i.e. nucleus of the tractus solitarius, NTS, and dorsal motor nucleus of the vagus, DMV) to examine the effects of corticotropin releasing hormone (CRF) on the central components of the vago-vagal reflex control of gastric function. When applied to gastrointestinal projecting DMV neurones, CRF (10-300 nM) induced a concentration-dependent membrane depolarization, an increase in action potential firing rate and decrease in amplitude of the action potential afterhyperpolarization (P < 0.05). Pretreatment with the non-selective CRF antagonist, astressin (0.5-1 μ) or the selective CRF2 receptor antagonist, astressin 2B (500 nM) attenuated the CRF-induced increase in firing rate but did not alter basal discharge rate. CRF (30-300 nM) increased the amplitude of excitatory postsynaptic currents (EPSCs) evoked by stimulation of the NTS (P < 0.05). An alteration in the paired pulse ratio indicated the EPSC's increase occurred due to actions at presynaptic sites. In the in vivo anaesthetized rat preparation, bilateral microinjections (20 fmol in 20 nl for each site) of CRF in the DVC decreased gastric motility in rats pretreated with the muscarinic agonist, bethanecol (P < 0.05). The effects of CRF were abolished by systemic administration of the NOS inhibitor, L-NAME, or by bilateral vagotomy. We concluded that CRF had both a direct and an indirect excitatory effect on DMV neurones via activation of CRF2 receptors and the decrease in gastric motility observed following microinjection of CRF in the DVC is due to the activation of an inhibitory non-adrenergic non-cholinergic input to the gastrointestinal tract.

Original languageEnglish (US)
Pages (from-to)135-146
Number of pages12
JournalJournal of Physiology
Volume543
Issue number1
DOIs
StatePublished - Aug 15 2002

Fingerprint

Corticotropin-Releasing Hormone
Stomach
Microinjections
Action Potentials
Bethanechol
Neurons
Muscarinic Agonists
Solitary Nucleus
Excitatory Postsynaptic Potentials
Vagotomy
NG-Nitroarginine Methyl Ester
Reflex
Gastrointestinal Tract
Membranes
In Vitro Techniques
CRF receptor type 2

All Science Journal Classification (ASJC) codes

  • Physiology

Cite this

Lewis, Mark W. ; Hermann, Gerlinda E. ; Rogers, Richard C. ; Travagli, R. Alberto. / In vitro and in vivo analysis of the effects of corticotropin releasing factor on rat dorsal vagal complex. In: Journal of Physiology. 2002 ; Vol. 543, No. 1. pp. 135-146.
@article{bc2996be6b2e4b43b34fb77ee7faf9cc,
title = "In vitro and in vivo analysis of the effects of corticotropin releasing factor on rat dorsal vagal complex",
abstract = "In vivo and in vitro electrophysiological experiments were performed on the rat dorsal vagal complex (DVC, i.e. nucleus of the tractus solitarius, NTS, and dorsal motor nucleus of the vagus, DMV) to examine the effects of corticotropin releasing hormone (CRF) on the central components of the vago-vagal reflex control of gastric function. When applied to gastrointestinal projecting DMV neurones, CRF (10-300 nM) induced a concentration-dependent membrane depolarization, an increase in action potential firing rate and decrease in amplitude of the action potential afterhyperpolarization (P < 0.05). Pretreatment with the non-selective CRF antagonist, astressin (0.5-1 μ) or the selective CRF2 receptor antagonist, astressin 2B (500 nM) attenuated the CRF-induced increase in firing rate but did not alter basal discharge rate. CRF (30-300 nM) increased the amplitude of excitatory postsynaptic currents (EPSCs) evoked by stimulation of the NTS (P < 0.05). An alteration in the paired pulse ratio indicated the EPSC's increase occurred due to actions at presynaptic sites. In the in vivo anaesthetized rat preparation, bilateral microinjections (20 fmol in 20 nl for each site) of CRF in the DVC decreased gastric motility in rats pretreated with the muscarinic agonist, bethanecol (P < 0.05). The effects of CRF were abolished by systemic administration of the NOS inhibitor, L-NAME, or by bilateral vagotomy. We concluded that CRF had both a direct and an indirect excitatory effect on DMV neurones via activation of CRF2 receptors and the decrease in gastric motility observed following microinjection of CRF in the DVC is due to the activation of an inhibitory non-adrenergic non-cholinergic input to the gastrointestinal tract.",
author = "Lewis, {Mark W.} and Hermann, {Gerlinda E.} and Rogers, {Richard C.} and Travagli, {R. Alberto}",
year = "2002",
month = "8",
day = "15",
doi = "10.1113/jphysiol.2002.019281",
language = "English (US)",
volume = "543",
pages = "135--146",
journal = "Journal of Physiology",
issn = "0022-3751",
publisher = "Wiley-Blackwell",
number = "1",

}

In vitro and in vivo analysis of the effects of corticotropin releasing factor on rat dorsal vagal complex. / Lewis, Mark W.; Hermann, Gerlinda E.; Rogers, Richard C.; Travagli, R. Alberto.

In: Journal of Physiology, Vol. 543, No. 1, 15.08.2002, p. 135-146.

Research output: Contribution to journalReview article

TY - JOUR

T1 - In vitro and in vivo analysis of the effects of corticotropin releasing factor on rat dorsal vagal complex

AU - Lewis, Mark W.

AU - Hermann, Gerlinda E.

AU - Rogers, Richard C.

AU - Travagli, R. Alberto

PY - 2002/8/15

Y1 - 2002/8/15

N2 - In vivo and in vitro electrophysiological experiments were performed on the rat dorsal vagal complex (DVC, i.e. nucleus of the tractus solitarius, NTS, and dorsal motor nucleus of the vagus, DMV) to examine the effects of corticotropin releasing hormone (CRF) on the central components of the vago-vagal reflex control of gastric function. When applied to gastrointestinal projecting DMV neurones, CRF (10-300 nM) induced a concentration-dependent membrane depolarization, an increase in action potential firing rate and decrease in amplitude of the action potential afterhyperpolarization (P < 0.05). Pretreatment with the non-selective CRF antagonist, astressin (0.5-1 μ) or the selective CRF2 receptor antagonist, astressin 2B (500 nM) attenuated the CRF-induced increase in firing rate but did not alter basal discharge rate. CRF (30-300 nM) increased the amplitude of excitatory postsynaptic currents (EPSCs) evoked by stimulation of the NTS (P < 0.05). An alteration in the paired pulse ratio indicated the EPSC's increase occurred due to actions at presynaptic sites. In the in vivo anaesthetized rat preparation, bilateral microinjections (20 fmol in 20 nl for each site) of CRF in the DVC decreased gastric motility in rats pretreated with the muscarinic agonist, bethanecol (P < 0.05). The effects of CRF were abolished by systemic administration of the NOS inhibitor, L-NAME, or by bilateral vagotomy. We concluded that CRF had both a direct and an indirect excitatory effect on DMV neurones via activation of CRF2 receptors and the decrease in gastric motility observed following microinjection of CRF in the DVC is due to the activation of an inhibitory non-adrenergic non-cholinergic input to the gastrointestinal tract.

AB - In vivo and in vitro electrophysiological experiments were performed on the rat dorsal vagal complex (DVC, i.e. nucleus of the tractus solitarius, NTS, and dorsal motor nucleus of the vagus, DMV) to examine the effects of corticotropin releasing hormone (CRF) on the central components of the vago-vagal reflex control of gastric function. When applied to gastrointestinal projecting DMV neurones, CRF (10-300 nM) induced a concentration-dependent membrane depolarization, an increase in action potential firing rate and decrease in amplitude of the action potential afterhyperpolarization (P < 0.05). Pretreatment with the non-selective CRF antagonist, astressin (0.5-1 μ) or the selective CRF2 receptor antagonist, astressin 2B (500 nM) attenuated the CRF-induced increase in firing rate but did not alter basal discharge rate. CRF (30-300 nM) increased the amplitude of excitatory postsynaptic currents (EPSCs) evoked by stimulation of the NTS (P < 0.05). An alteration in the paired pulse ratio indicated the EPSC's increase occurred due to actions at presynaptic sites. In the in vivo anaesthetized rat preparation, bilateral microinjections (20 fmol in 20 nl for each site) of CRF in the DVC decreased gastric motility in rats pretreated with the muscarinic agonist, bethanecol (P < 0.05). The effects of CRF were abolished by systemic administration of the NOS inhibitor, L-NAME, or by bilateral vagotomy. We concluded that CRF had both a direct and an indirect excitatory effect on DMV neurones via activation of CRF2 receptors and the decrease in gastric motility observed following microinjection of CRF in the DVC is due to the activation of an inhibitory non-adrenergic non-cholinergic input to the gastrointestinal tract.

UR - http://www.scopus.com/inward/record.url?scp=0037101914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037101914&partnerID=8YFLogxK

U2 - 10.1113/jphysiol.2002.019281

DO - 10.1113/jphysiol.2002.019281

M3 - Review article

C2 - 12181286

AN - SCOPUS:0037101914

VL - 543

SP - 135

EP - 146

JO - Journal of Physiology

JF - Journal of Physiology

SN - 0022-3751

IS - 1

ER -